Display options
Cite
Robinson ER, Walker TM, Pallen MJ. Genomics and outbreak investigation: from sequence to consequence. Genome Med. 2013;5(4):36doi: 10.1186/gm440.
Robinson, E. R., Walker, T. M., & Pallen, M. J. (2013). Genomics and outbreak investigation: from sequence to consequence. Genome medicine, 5(4), 36. https://doi.org/10.1186/gm440
Robinson, Esther R, et al. "Genomics and outbreak investigation: from sequence to consequence." Genome medicine vol. 5,4 (2013): 36. doi: https://doi.org/10.1186/gm440
Robinson ER, Walker TM, Pallen MJ. Genomics and outbreak investigation: from sequence to consequence. Genome Med. 2013 Apr 29;5(4):36. doi: 10.1186/gm440. eCollection 2013. PMID: 23673226; PMCID: PMC3706975.
Copy Download .nbib Format: NLM
Share it on

Genome Med. 2013 Apr 29;5(4):36. doi: 10.1186/gm440. eCollection 2013.

Genomics and outbreak investigation: from sequence to consequence.

Genome medicine

Esther R Robinson, Timothy M Walker, Mark J Pallen

Affiliations

  1. Oxford University Hospitals NHS Trust, Oxford, OX3 9DU, UK.
  2. Nuffield Department of Clinical Medicine, University of Oxford, OX3 7LJ, UK.
  3. Division of Microbiology and Infection, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.

PMID: 23673226 PMCID: PMC3706975 DOI: 10.1186/gm440

Abstract

Outbreaks of infection can be devastating for individuals and societies. In this review, we examine the applications of new high-throughput sequencing approaches to the identification and characterization of outbreaks, focusing on the application of whole-genome sequencing (WGS) to outbreaks of bacterial infection. We describe traditional epidemiological analysis and show how WGS can be informative at multiple steps in outbreak investigation, as evidenced by many recent studies. We conclude that high-throughput sequencing approaches can make a significant contribution to the investigation of outbreaks of bacterial infection and that the integration of WGS with epidemiological investigation, diagnostic assays and antimicrobial susceptibility testing will precipitate radical changes in clinical microbiology and infectious disease epidemiology in the near future. However, several challenges remain before WGS can be routinely used in outbreak investigation and clinical practice.

References

  1. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5 - PubMed
  2. Curr Opin Pulm Med. 2013 May;19(3):266-72 - PubMed
  3. Genome Biol. 2012 Dec 21;13(12):R118 - PubMed
  4. Clin Microbiol Infect. 2013 Jan;19(1):15-22 - PubMed
  5. J Clin Microbiol. 1996 Jul;34(7):1870 - PubMed
  6. J Clin Microbiol. 2003 Aug;41(8):3514-20 - PubMed
  7. N Engl J Med. 2011 Nov 10;365(19):1763-70 - PubMed
  8. N Engl J Med. 2011 Nov 10;365(19):1771-80 - PubMed
  9. Nat Rev Genet. 2012 Feb 07;13(3):175-88 - PubMed
  10. Nat Genet. 2012 Sep;44(9):1056-9 - PubMed
  11. Electrophoresis. 2012 Dec;33(23):3418-28 - PubMed
  12. Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S66-9 - PubMed
  13. Biotechnol J. 2012 Sep;7(9):1063-73 - PubMed
  14. Clin Microbiol Rev. 1999 Oct;12(4):612-26 - PubMed
  15. Lancet Infect Dis. 2013 Feb;13(2):137-46 - PubMed
  16. BMC Bioinformatics. 2010 Dec 10;11:595 - PubMed
  17. Nat Med. 2012 May;18(5):816-9 - PubMed
  18. Genome Res. 2013 Apr;23(4):653-64 - PubMed
  19. PLoS Pathog. 2008 Nov;4(11):e1000212 - PubMed
  20. Int J Antimicrob Agents. 2012 Apr;39(4):273-82 - PubMed
  21. N Engl J Med. 2011 Feb 24;364(8):730-9 - PubMed
  22. J Infect Dis. 2006 Sep 15;194 Suppl 1:S51-8 - PubMed
  23. Nat Rev Genet. 2010 Jan;11(1):31-46 - PubMed
  24. PLoS One. 2012;7(11):e47983 - PubMed
  25. Nat Rev Genet. 2012 Sep;13(9):601-612 - PubMed
  26. mBio. 2011 Sep 01;2(4):e00157-11 - PubMed
  27. Genome Med. 2011 Aug 23;3(8):53 - PubMed
  28. Euro Surveill. 2013 Jan 24;18(4):20384 - PubMed
  29. Virol J. 2013 Jan 25;10:32 - PubMed
  30. Infect Genet Evol. 2013 Jun;16:38-53 - PubMed
  31. Nat Genet. 2011 May;43(5):482-6 - PubMed
  32. Lancet Infect Dis. 2013 Feb;13(2):130-6 - PubMed
  33. Nat Biotechnol. 2012 Nov;30(11):1068-71 - PubMed
  34. BMJ Open. 2012 Jun 06;2(3): - PubMed
  35. Genomics. 2009 Feb;93(2):105-11 - PubMed
  36. J Hosp Infect. 2010 May;75(1):37-41 - PubMed
  37. N Engl J Med. 2011 Apr 28;364(17):1626-33 - PubMed
  38. Nat Rev Genet. 2012 Mar 28;13(5):303-14 - PubMed
  39. Nature. 2011 Aug 24;477(7365):462-5 - PubMed
  40. Nat Biotechnol. 2012 May;30(5):434-9 - PubMed
  41. mBio. 2012 Nov 20;3(6): - PubMed
  42. Euro Surveill. 2013 Jan 24;18(4):20380 - PubMed
  43. Nat Biotechnol. 2013 Mar;31(3):247-50 - PubMed
  44. Open Biol. 2011 Oct;1(2):110008 - PubMed
  45. Nat Genet. 2013 Jan;45(1):109-13 - PubMed
  46. Nat Rev Microbiol. 2012 Sep;10(9):599-606 - PubMed
  47. Curr Opin Microbiol. 2010 Oct;13(5):625-31 - PubMed
  48. J Clin Microbiol. 2012 Sep;50(9):3046-53 - PubMed
  49. N Engl J Med. 2011 Aug 25;365(8):718-24 - PubMed
  50. JAMA. 2013 Apr 10;309(14):1502-10 - PubMed
  51. Clin Infect Dis. 2012 Jun;54(11):1588-94 - PubMed
  52. Infect Dis Clin North Am. 2010 Mar;24(1):175-202 - PubMed
  53. Nat Genet. 2010 Dec;42(12):1140-3 - PubMed
  54. N Engl J Med. 2008 Mar 6;358(10):991-8 - PubMed
  55. Science. 2011 Jan 28;331(6016):430-4 - PubMed
  56. Infect Genet Evol. 2012 Mar;12(2):214-26 - PubMed
  57. Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4550-5 - PubMed
  58. PLoS Pathog. 2012;8(11):e1003008 - PubMed

Publication Types

Grant support